D
Dong Choon Park
Researcher at Catholic University of Korea
Publications - 82
Citations - 1571
Dong Choon Park is an academic researcher from Catholic University of Korea. The author has contributed to research in topics: Medicine & Cervical cancer. The author has an hindex of 17, co-authored 67 publications receiving 1370 citations. Previous affiliations of Dong Choon Park include Harvard University & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
Tomas Bonome,Ji Young Lee,Dong Choon Park,Mike Radonovich,Cindy Pise-Masison,John N. Brady,Ginger J. Gardner,Ke Hao,Wing Hung Wong,J. Carl Barrett,Karen H. Lu,Anil K. Sood,David M. Gershenson,Samuel C. Mok,Michael J. Birrer +14 more
TL;DR: The expression profiles of LMP, low-grade, and high- grade papillary serous ovarian carcinomas suggest that LMP tumors are distinct from high-grade cancers; however, they are remarkably similar to low- grade cancers.
Journal ArticleDOI
A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2
Samuel C. Mok,Tomas Bonome,Vinod Vathipadiekal,Aaron Bell,Michael E. Johnson,Kwong Kwok Wong,Dong Choon Park,Dong Choon Park,Ke Hao,Daniel K.P. Yip,Howard Donninger,Laurent Ozbun,Goli Samimi,John N. Brady,Mike Randonovich,Cindy Pise-Masison,J. Carl Barrett,Wing Hung Wong,William R. Welch,Ross S. Berkowitz,Ross S. Berkowitz,Michael J. Birrer +21 more
TL;DR: Independent evaluation confirmed the association of a prognostic gene microfibril-associated glycoprotein 2 (MAGP2) with poor prognosis, whereas in vitro mechanistic analyses demonstrated its ability to prolong tumor cell survival and stimulate endothelial cell motility and survival via the alpha(V)beta(3) integrin receptor.
Journal ArticleDOI
Whole Genome Oligonucleotide-Based Array Comparative Genomic Hybridization Analysis Identified Fibroblast Growth Factor 1 As a Prognostic Marker for Advanced-Stage Serous Ovarian Adenocarcinomas
Michael J. Birrer,Michael E. Johnson,Ke Hao,Kwong Kwok Wong,Dong Choon Park,Aaron Bell,William R. Welch,Ross S. Berkowitz,Samuel C. Mok +8 more
TL;DR: Amplification of FGF-1 at 5q31 in ovarian cancer tissues leads to increased angiogenesis, and autocrine stimulation of cancer cells, which may result in poorer overall survival in patents with high-grade advanced stage serous ovarian cancer.
Journal Article
Identification of Epithelial Cell Adhesion Molecule Autoantibody in Patients with Ovarian Cancer
Jae Hoon Kim,Dorothee Herlyn,Kwong Kwok Wong,Dong Choon Park,Dong Choon Park,John O. Schorge,Karen H. Lu,Steven J. Skates,Daniel W. Cramer,Ross S. Berkowitz,Samuel C. Mok +10 more
TL;DR: This investigation has shown that the Ep-CAM autoantibody was found to be associated with ovarian cancer and suggested that future research assessing its clinical usefulness would be worthwhile.
Journal ArticleDOI
Selenium binding protein 1 in ovarian cancer.
Kuan-Chun Huang,Dong Choon Park,Shu-Kay Ng,Ji Young Lee,Xiaoyan Ni,Wing Chung Ng,Christina A. Bandera,William R. Welch,Ross S. Berkowitz,Samuel C. Mok,Shu Wing Ng +10 more
TL;DR: Results suggest that changes of SELENBP1 expression in malignant ovarian cancer are an indicator of aberration of selenium/androgen pathways and may reveal prognostic information of ovarian cancer.